Hepatitis C antibody reactivity among high-risk rural women: opportunities for services and treatment in the criminal justice system

Date11 June 2018
Pages89-100
Published date11 June 2018
DOIhttps://doi.org/10.1108/IJPH-03-2017-0012
AuthorJustin C. Strickland,Michele Staton,Carl G. Leukefeld,Carrie B. Oser,J. Matthew Webster
Subject MatterHealth & social care,Criminology & forensic psychology,Prisoner health,Sociology,Sociology of crime & law,Public policy & environmental management,Policing,Criminal justice
Hepatitis C antibody reactivity among
high-risk rural women: opportunities for
services and treatment in the criminal
justice system
Justin C. Strickland, Michele Staton, Carl G. Leukefeld, Carrie B. Oser and
J. Matthew Webster
Abstract
Purpose The purpose of this paper is to examine the drug use and criminal justice factors related to
hepatitis C virus (HCV) antibody reactivity among rural women in the USA recruited from local jails.
Design/methodology/approach Analyses included 277 women with a history of injection drug use from
three rural jails in Kentucky. Participants completed health and drug use questionnaires and received
antibody testing for HCV.
Findings The majority of women tested reactive to the HCV antibody (69 percent). Reactivity was
associated with risk factors, such as unsterile needle use. Criminal justice variables, including an increased
likelihood of prison incarceration, an earlier age of first arrest, and a longer incarceration history, were
associated with HCV reactive tests. Participants also endorsed several barriers to seeking healthcare before
entering jail that were more prevalent in women testing HCV reactive regardless of HCV status awareness
before entering jail.
Originality/value Injection and high-risk sharing practices as well as criminal justice factors were
significantly associated with HCV reactivity. Future research and practice could focus on opportunities for
linkages to HCV treatment during incarceration as well as during community re-entry to help overcome real or
perceived treatment barriers. The current study highlights the importance of the criminal justice system as a
non-traditional, real-world setting to examine drug use and related health consequences such as HCV by
describing the association of high-risk drug use and criminal justice consequences with HCV among rural
women recruited from local jails.
Keywords Offender health, Cocaine, Substance use, Barriers, Jail, Injection drug use
Paper type Research paper
Introduction
Drug use and misuse are associated with physical health impediments to living a longer, healthier
life, including cardiovascular toxicity, respiratory damage, and the acquisition and transmission of
sexually transmitted infections (e.g. Stein, 1999). These outcomes may result from the direct
effects of the substance used or the increased likelihood of risky sexual or drug use behaviors
(e.g. unprotected sexual intercourse; unsterile needle use) throughout the procurement of,
engagement in, and period following substance use. For example, injection drug use (IDU)
increases transmission risk for infections such as the hepatitis C virus (HCV) (Alter, 2007).
Incarcerated populations may represent a population at particular risk for infection transmission
given the high rates of IDU among individuals in jails and prisons in the USA and internationally
(e.g. Boutwell et al., 2007; Dolan et al., 2015; World Health Organization, 1994). Targeting health
consequences of drug use could further elucidate risk factors underlying susceptibility and help
to identify novel venues for interventions in the criminal justice system.
Received 1 March 2017
Revised 5 July 2017
Accepted 11 July 2017
The authors affiliations can be
found at the end of this article.
DOI 10.1108/IJPH-03-2017-0012 VOL. 14 NO. 2 2018, pp. 89-100, © Emerald Publishing Limited, ISSN 1744-9200
j
INTERNATIONALJOURNAL OF PRISONER HEALTH
j
PAG E 89

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT